Paolo Fusar-Poli
Paolo Fusar-Poli is an Italian and British medical doctor, psychiatrist, and Professor at the Institute of Psychiatry, Psychology and Neuroscience, King's College, London and at the Department of Brain and Behavioral Sciences, University of Pavia.
Provided by Wikipedia
Showing 1 - 20 results of 23 for search 'Paolo Fusar-Poli', query time: 0.04s
Refine Results
-
1
Local adaptation and validation of a transdiagnostic risk calculator for first episode psychosis using mental health patient records by Elizabeth Ford, James Stone, James Stone, James Stone, Dominic Oliver, Dominic Oliver, Dominic Oliver, Benjamin Fell, Gloria Roque, Sam Robertson, Paolo Fusar-Poli, Paolo Fusar-Poli, Paolo Fusar-Poli, Paolo Fusar-Poli, Kathryn Greenwood, Kathryn Greenwood
Published 2025-07-01Get full text
Article -
2
-
3
Psychological, psychiatric, and behavioral sciences measurement scales: best practice guidelines for their development and validation by Alberto Stefana, Stefano Damiani, Umberto Granziol, Umberto Provenzani, Marco Solmi, Marco Solmi, Marco Solmi, Marco Solmi, Marco Solmi, Eric A. Youngstrom, Eric A. Youngstrom, Eric A. Youngstrom, Paolo Fusar-Poli, Paolo Fusar-Poli, Paolo Fusar-Poli
Published 2025-01-01Get full text
Article -
4
-
5
-
6
-
7
Allostatic load index across the psychosis spectrum: a systematic review and meta-analysis by Lander Madaria, Lander Madaria, Lander Madaria, Claudia Aymerich, Claudia Aymerich, Claudia Aymerich, Borja Pedruzo, Borja Pedruzo, Borja Pedruzo, Borja Pedruzo, Gonzalo Salazar de Pablo, Gonzalo Salazar de Pablo, Gonzalo Salazar de Pablo, Daniel Alonso-Alconada, Paolo Fusar-Poli, Paolo Fusar-Poli, Paolo Fusar-Poli, Miguel Ángel Gonzalez-Torres, Miguel Ángel Gonzalez-Torres, Miguel Ángel Gonzalez-Torres, Miguel Ángel Gonzalez-Torres, Ana Catalan, Ana Catalan, Ana Catalan, Ana Catalan, Ana Catalan
Published 2025-07-01Get full text
Article -
8
Correction: Allostatic load index across the psychosis spectrum: a systematic review and meta-analysis by Lander Madaria, Lander Madaria, Lander Madaria, Claudia Aymerich, Claudia Aymerich, Claudia Aymerich, Borja Pedruzo, Borja Pedruzo, Borja Pedruzo, Borja Pedruzo, Gonzalo Salazar de Pablo, Gonzalo Salazar de Pablo, Gonzalo Salazar de Pablo, Daniel Alonso-Alconada, Paolo Fusar-Poli, Paolo Fusar-Poli, Paolo Fusar-Poli, Miguel Ángel Gonzalez-Torres, Miguel Ángel Gonzalez-Torres, Miguel Ángel Gonzalez-Torres, Miguel Ángel Gonzalez-Torres, Ana Catalan, Ana Catalan, Ana Catalan, Ana Catalan, Ana Catalan
Published 2025-08-01Get full text
Article -
9
-
10
Cannabidiol as a treatment for patients who are clinically at high risk of developing psychosis: learnings from the CANTOP-RCT by Sagnik Bhattacharyya, Cathy Davies, Ben Carter, Philip McGuire, Michael Brammer, Paolo Fusar-Poli, Matthew Broome, Stuart Watson, Jesus Perez, Alison Yung
Published 2025-03-01Get full text
Article -
11
Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. by Albert Batalla, Sagnik Bhattacharyya, Murat Yücel, Paolo Fusar-Poli, Jose Alexandre Crippa, Santiago Nogué, Marta Torrens, Jesús Pujol, Magí Farré, Rocio Martin-Santos
Published 2013-01-01Get full text
Article -
12
Factors associated with drug–drug interactions involving citalopram in the UK Biobank by Benjamin Laplace, Win Lee Edwin Wong, Marco Menchetti, Diana De Ronchi, Paolo Fusar-Poli, Giuseppe Fanelli, MNESYS – Mood and Psychosis Sub-Project (Spoke 5), Alessandro Serretti, Cathryn M. Lewis, Chiara Fabbri
Published 2025-09-01Get full text
Article -
13
Prevalence and predictors of healthcare use for psychiatric disorders at 9 years after a first episode of psychosis: a Swedish national cohort study by Ellenor Mittendorfer-Rutz, Heidi Taipale, Annette Erlangsen, Alexis E Cullen, Philip McGuire, Dan W Joyce, Paolo Fusar-Poli, Carsten Hjorthøj, Nikolai Albert, Donna van Deursen, Emma Pettersson, Meredete Nordentoft, Simon Cervenka
Published 2025-03-01Get full text
Article -
14
Peripheral inflammation and neurocognitive functioning in early psychosis: Specific associations of TNF-α and IL-6 with social cognition by Ana Catalán, Claudia Aymerich, José Manuel Rodríguez-Sánchez, Borja Pedruzo, Gonzalo Salazar de Pablo, Patxi Gil, Francisco Aguayo, Garazi Acasuso, Alvaro Collado-Pérez, Javier Goena, Olatz Ibarretxe, Iñaki Zorrilla, Ana González-Pinto, Leire Erkoreka, Daniel Alonso-Alconada, Paolo Fusar-Poli, Miguel Angel González-Torres
Published 2025-01-01Get full text
Article -
15
PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample by Stefania Tognin, Sandra Vieira, Dominic Oliver, Alexis E. Cullen, Mathew J. Kempton, Paolo Fusar-Poli, Andrea Mechelli, Paola Dazzan, Kate Merritt, Arija Maat, Lieuwe de Haan, Stephen M. Lawrie, Thérèse van Amelsvoort, Celso Arango, Barnaby Nelson, Silvana Galderisi, Rodrigo Bressan, Jun Soo Kwon, Romina Mizrahi, the PSYSCAN Consortium, Rene S. Kahn, Philip McGuire
Published 2025-04-01Get full text
Article -
16
Bridging Science and Hope: integrating and Communicating Lived experience in Accelerating Medicines Partnership® Schizophrenia Program by Ameneh Asgari-Targhi, Beier Yao, Lisa Brown, Suzanne Garcia, Arundati Nagendra, Kota Chin, Tashrif Billah, Nora Penzel, Omar John, Nicholas Prunier, Simone Veale, Elana Kotler, Grace R. Jacobs, Ming Zhan, Michael J. Coleman, Sylvain Bouix, Ofer Pasternak, Guillermo Cecci, Justin T. Baker, Daniel H. Mathalon, Sinead M. Kelly, Cheryl M. Corcoran, Abraham Reichenberg, Inge Winter-van Rossum, Marek Kubicki, Jessica Spark, Dominic Dwyer, Celso Arango, Paolo Fusar-Poli, Monica Calkins, Jai L. Shah, Vijay Mittal, Andrew Thompson, Patrick D. McGorry, René S. Kahn, John M. Kane, Carrie E. Bearden, Scott W. Woods, Barnaby Nelson, Martha E. Shenton, Brandon Staglin, the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Carlos A. Larrauri, Kathryn Eve Lewandowski, Tina Kapur
Published 2025-04-01Get full text
Article -
17
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program by Nora Penzel, Pablo Polosecki, Jean Addington, Celso Arango, Ameneh Asgari-Targhi, Tashrif Billah, Sylvain Bouix, Monica E. Calkins, Dylan E. Campbell, Tyrone D. Cannon, Eduardo Castro, Kang Ik K. Cho, Michael J. Coleman, Cheryl M. Corcoran, Dominic Dwyer, Sophia Frangou, Paolo Fusar-Poli, Robert J. Glynn, Anastasia Haidar, Michael P. Harms, Grace R. Jacobs, Joseph Kambeitz, Tina Kapur, Sinead M. Kelly, Nikolaos Koutsouleris, K. R. Abhinandan, Saryet Kucukemiroglu, Jun Soo Kwon, Kathryn E. Lewandowski, Qingqin S. Li, Valentina Mantua, Daniel H. Mathalon, Vijay A. Mittal, Spero Nicholas, Gahan J. Pandina, Diana O. Perkins, Andrew Potter, Abraham Reichenberg, Jenna Reinen, Michael S. Sand, Johanna Seitz-Holland, Jai L. Shah, Vairavan Srinivasan, Agrima Srivastava, William S. Stone, John Torous, Mark G. Vangel, Jijun Wang, Phillip Wolff, Beier Yao, Alan Anticevic, Daniel H. Wolf, Hao Zhu, Carrie E. Bearden, Patrick D. McGorry, Barnaby Nelson, John M. Kane, Scott W. Woods, René S. Kahn, Martha E. Shenton, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Guillermo Cecchi, Ofer Pasternak
Published 2025-04-01Get full text
Article -
18
Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program by Tashrif Billah, Kang Ik K. Cho, Owen Borders, Yoonho Chung, Michaela Ennis, Grace R. Jacobs, Einat Liebenthal, Daniel H. Mathalon, Dheshan Mohandass, Spero C. Nicholas, Ofer Pasternak, Nora Penzel, Habiballah Rahimi Eichi, Phillip Wolff, Alan Anticevic, Kristen Laulette, Angela R. Nunez, Zailyn Tamayo, Kate Buccilli, Beau-Luke Colton, Dominic B. Dwyer, Larry Hendricks, Hok Pan Yuen, Jessica Spark, Sophie Tod, Holly Carrington, Justine T. Chen, Michael J. Coleman, Cheryl M. Corcoran, Anastasia Haidar, Omar John, Sinead Kelly, Patricia J. Marcy, Priya Matneja, Alessia McGowan, Susan E. Ray, Simone Veale, Inge Winter-Van Rossum, Jean Addington, Kelly A. Allott, Monica E. Calkins, Scott R. Clark, Ruben C. Gur, Michael P. Harms, Diana O. Perkins, Kosha Ruparel, William S. Stone, John Torous, Alison R. Yung, Eirini Zoupou, Paolo Fusar-Poli, Vijay A. Mittal, Jai L. Shah, Daniel H. Wolf, Guillermo Cecchi, Tina Kapur, Marek Kubicki, Kathryn Eve Lewandowski, Carrie E. Bearden, Patrick D. McGorry, René S. Kahn, John M. Kane, Barnaby Nelson, Scott W. Woods, Martha E. Shenton, the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Justin T. Baker, Sylvain Bouix
Published 2025-04-01Get full text
Article -
19
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program by Johanna T. W. Wigman, Ann Ee Ching, Yoonho Chung, Habiballah Rahimi Eichi, Erlend Lane, Carsten Langholm, Aditya Vaidyam, Andrew Jin Soo Byun, Anastasia Haidar, Jessica Hartmann, Angela Nunez, Dominic Dwyer, Adibah Amani Nasarudin, Owen Borders, Isabelle Scott, Zailyn Tamayo, Priya Matneja, Kang-Ik Cho, Jean Addington, Luis K. Alameda, Celso Arango, Nicholas J. K. Breitborde, Matthew R. Broome, Kristin S. Cadenhead, Monica E. Calkins, Eric Yu Hai Chen, Jimmy Choi, Philippe Conus, Cheryl M. Corcoran, Barbara A. Cornblatt, Covadonga M. Diaz-Caneja, Lauren M. Ellman, Paolo Fusar-Poli, Pablo A. Gaspar, Carla Gerber, Louise Birkedal Glenthøj, Leslie E. Horton, Christy Lai Ming Hui, Joseph Kambeitz, Lana Kambeitz-Ilankovic, Matcheri S. Keshavan, Sung-Wan Kim, Nikolaos Koutsouleris, Kerstin Langbein, Daniel Mamah, Daniel H. Mathalon, Vijay A. Mittal, Merete Nordentoft, Godfrey D. Pearlson, Jesus Perez, Diana O. Perkins, Albert R. Powers, Jack Rogers, Fred W. Sabb, Jason Schiffman, Jai L. Shah, Steven M. Silverstein, Stefan Smesny, Walid Yassin, William S. Stone, Gregory P. Strauss, Judy L. Thompson, Rachel Upthegrove, Swapna Verma, Jijun Wang, Daniel H. Wolf, Phillip Wolff, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Laura M. Rowland, Simon D’Alfonso, Ofer Pasternak, Sylvain Bouix, Patrick D. McGorry, Rene S. Kahn, John M. Kane, Carrie E. Bearden, Scott W. Woods, Martha E. Shenton, Barnaby Nelson, Justin T. Baker, John Torous
Published 2025-06-01Get full text
Article -
20
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program by Jean Addington, Lu Liu, Amy Braun, Andrea Auther, Monica E. Calkins, Barbara A. Cornblatt, Cheryl M. Corcoran, Paolo Fusar-Poli, Melissa J. Kerr, Catalina V. Mourgues-Codern, Angela R. Nunez, Dominic Oliver, Gregory P. Strauss, Barbara C. Walsh, Luis K. Alameda, Celso Arango, Nicholas J. K. Breitborde, Matthew R. Broome, Kristin S. Cadenhead, Ricardo E. Carrion, Eric Yu Hai Chen, Jimmy Choi, Michael J. Coleman, Philippe Conus, Covadonga M. Diaz-Caneja, Dominic Dwyer, Lauren M. Ellman, Masoomeh Faghankhani, Pablo A. Gaspar, Carla Gerber, Louise Birkedal Glenthøj, Leslie E. Horton, Christy Hui, Grace R. Jacobs, Joseph Kambeitz, Lana Kambeitz-Ilankovic, Matcheri S. Keshavan, Sung-Wan Kim, Nikolaos Koutsouleris, Jun Soo Kwon, Kerstin Langbein, Kathryn E. Lewandowski, Daniel Mamah, Patricia J. Marcy, Daniel H. Mathalon, Vijay A. Mittal, Merete Nordentoft, Godfrey D. Pearlson, Nora Penzel, Jesus Perez, Diana O. Perkins, Albert R. Powers, Jack Rogers, Fred W. Sabb, Jason Schiffman, Jai L. Shah, Steven M. Silverstein, Stefan Smesny, William S. Stone, Andrew Thompson, Judy L. Thompson, Rachel Upthegrove, Swapna Verma, Jijun Wang, Heather M. Wastler, Alana Wickham, Inge Winter-van Rossum, Daniel H. Wolf, Sylvain Bouix, Ofer Pasternak, Rene S. Kahn, Carrie E. Bearden, John M. Kane, Patrick D. McGorry, Kate Buccilli, Barnaby Nelson, Martha E. Shenton, Scott W. Woods, the Accelerating Medicines Partnership® -Schizophrenia, Alison R. Yung
Published 2025-04-01Get full text
Article